Introduction
Febrile urinary tract infections (UTIs) are common in children. In infants presenting with unexplained fever the prevalence of UTI is 7%, reaching 20% in uncircumcised boys by three months of age [
1]. These febrile UTIs are said to lead to pyelonephritic scarring in up to 30% of cases, and can be the first sign of a congenital abnormality of the kidney and urinary tract, the most frequent being vesicoureteral reflux (VUR), which occurs in one-third of cases [
2]. The observation that VUR is a risk factor for recurrent infection, and the finding of an association between VUR (primarily high-grade) and chronic kidney damage, originally led to a push from the medical and surgical world to try to detect VUR after a febrile UTI, with the implementation of continuous antibiotic prophylaxis or surgical correction in the event of finding it. In recent years, there has been a reassessment of the role of VUR and acquired pyelonephritic scarring as risk factors for progressive chronic kidney disease and other long-term consequences [
3,
4], and thus of the need to investigate children following a first febrile UTI.
The role of the pediatric radiologist is to decide whether a voiding cystourethrogram (VCUG), the standard test for VUR, is justified in an individual patient, and if so to perform and interpret it. A first febrile UTI in a young child can present to a pediatrician or a pediatric surgeon.
We are aware of an interesting paper that appeared in the BMJ some years ago entitled “Phenotypic differences between male physicians, surgeons and film stars: comparative study,” where evidence-based medicine was contrasted with confidence-based medicine [
5]. A further paper by Stirrat also provided an insight into surgical thinking [
6]. In multidisciplinary discussions among radiologists, physicians, and surgeons at our institutions, it has become apparent that stark differences have developed in the medical and surgical approaches to investigation and management of this common condition.
To what extent are differences in approach to febrile UTIs present in the literature, and if so, what are the justifications? To answer these questions, we reviewed the literature, comparing the approaches of physicians and surgeons to investigation and treatment.
Discussion
The literature search performed during the 11-year period from 2011, when the revised American Academy of Pediatrics guidelines on the investigation and management of a first febrile UTI in infancy were published, largely concurring with the earlier National Institute for Health and Care Excellence guidelines, demonstrated significant differences in approach between physicians and surgeons in terms of imaging, antibiotic prophylaxis, and surgery in the event of VUR detection. It should be clarified that this is not a systematic review or meta-analysis, which represent scholarly syntheses of evidence on a subject to inform healthcare decisions. While physicians have largely embraced evidence-based medicine, surgeons in many cases have not; thus, any systematic review or meta-analysis would potentially exclude large portions of the surgical literature and thus make any assessment of conflicting views between the two groups impossible.
An analysis of the papers identifies some indication of the justifications given by physicians and surgeons for the divergence of opinion. Physicians as a group, in line with the newer evidence-based guidelines, advocate less imaging and intervention, and are inclined to adopt a “watchful-waiting” approach, confident that any significant abnormality, grade IV–V VUR in particular, should be picked up following a second febrile UTI. In contrast, surgeons as a group are more likely to recommend imaging to detect VUR, with antibiotic prophylaxis and/or surgical correction if it is detected, concerned that any delay in diagnosis and treatment could place the child at risk of kidney damage. This divergence of approach between physicians and surgeons often confuses the family of the child, regarding the choice of how to best proceed with the diagnostic and therapeutic process.
Physicians have for the most part embraced evidence-based medicine following its inception at McMaster University in 1991 [
131]. In 2007, the BMJ conducted an international poll to determine the most important medical milestones in healthcare. Evidence-based medicine came seventh, ahead of the computer and medical imaging [
132]. Surgeons have been more tempered in accepting the evidence-based concept [
133]. It would be easy to be dismissive of surgeons who do not practice evidence-based medicine; however, physicians had similar reservations initially [
134]. Stirrat, who has previously published on the challenge of evaluating surgical procedures [
135], explored the experiential nature of surgery and reasons for the slow uptake of evidence-based surgery. He acknowledges the benefits of evidence-based medicine but expresses concern regarding over-reliance on RCTs, and a lack of generalizability of evidence to individual patients. These remain valid concerns, particularly when there is absent, incomplete, or conflicting evidence as well as the recognition that RCTs determine net results in the groups studied, while the probabilities are not precisely transferable to all individuals within the groups [
136]. These may be factors leading to less enthusiasm for the tenets of evidence-based medicine amongst surgeons. He also noted that surgeons often used historical controls, comparing the results of a new operation with those obtained using another procedure. This introduces serious bias due to the assumption that nothing has changed apart from the new procedure, with incorrect conclusions in 40–60% of such studies. Weil [
137], in a commentary on the lack of RCTs in surgery, noted that “The case series remains a favored method of clinical investigation in surgery. Case series are easy to perform, require less resources in terms of personnel and funds, can be performed at a single center, and, for many surgeons, represent a means to illustrate their surgical method and skills.” This concern is particularly relevant to the large number of studies on surgical technique to correct VUR, where success rates in resolving VUR were paramount, with little or no discussion on the indications or outcomes.
Following the recognition by improved antenatal ultrasound of congenital abnormalities of the kidney and urinary tract as a major reason for extensive renal damage, along with RCTs demonstrating medical intervention (continuous antibiotic prophylaxis) to be largely ineffective in preventing febrile UTIs, with no effect on scarring [
125], updated evidence-based guidelines in the medical literature have led to a marked reduction in the investigations performed, and treatment prescribed by physicians following a first febrile UTI [
138] (Table
3). In contrast, many surgeons remain focused on VUR, as a disease to be investigated for and treated, in the absence of any prospective RCTs demonstrating benefit for their intervention, so much so that the largest group of studies in the surgical literature assess surgical techniques for correcting VUR without alluding to any indications for the procedures.
Table 3
Published guidelines for imaging following a first febrile urinary tract infection
NICE | <6/12 Yes >6/12 atypical UTI | No unless abnormal US or atypical UTI | Atypical UTI |
| Yes | No unless abnormal US | No |
| Yes | No unless abnormal US or risk factors | Abnormal US and/or VUR |
| No unless absent antenatal US, atypical UTI, mass, poor stream, slow response | No unless recurrent febrile UTIs or US suggestive of posterior urethral valve | No unless reduced kidney function |
| Yes | No unless abnormal US suggestive of obstruction or high grade VUR | |
| Yes | Yes consider after second febrile UTI in boys >1 year with option of a “top down” approach performing DMSA instead and VCUG if positive | No DMSA if VCUG positive or VCUG if DMSA positive |
Urology Section AAP 2012 [ 74] b | Yes | Yes | No |
This is not universally the case, however, with other surgeons stating that “vesicoureteral reflux is a phenotype not a disease” and is thus inconsequential [
47]. Furthermore, RCTs in children with VUR that compared continuous antibiotic prophylaxis with surgical correction, demonstrated a low incidence of subsequent scarring with no significant difference between treatment arms, although no study has had a no-treatment control group [
144‐
146].
An additional factor often raised is the mode of practice. Physicians and surgeons graduate from the same medical schools, after which their training diverges. Physicians focus on lifestyle counselling and medication where appropriate, often involving a long-term palliative rather than a curative approach, with the ability to re-assess management as newer information becomes available. Surgeons perform definitive procedures that historically were emergency interventions, such as appendectomy, with a predominance of elective procedures only developing in recent times. Regardless, given the invasive nature and irreversibility of operations, surgeons must have a strong belief in the curative nature of their interventions to convince patients, or the parents of patients, to consent. Are the differences phenotypic with different inherent traits determining the training path undertaken, as suggested in the BMJ paper [
5], or are they the consequence of different approaches to training, as proposed by Stirrat [
6]?
Comments such as “the literature obfuscates more than it clarifies” [
82], “these guidelines do not reflect the real world” [
129], and assertions that some guidelines (National Institute for Health and Care Excellence, American Academy of Pediatrics and Italian included) “are driven by economic and health care issues” [
143], pervade the surgical literature. The admonition “You can’t handle the truth!” has even been applied to the pediatric community when they debate the need for continuous antibiotic prophylaxis in children following a UTI [
82].
The 2008 National Institute for Health and Care Excellence evidence-based guidelines on UTI in infants and young children were the first to advocate reduced imaging and intervention [
139]. Thereafter, published physician-instigated guidelines largely concurred with the National Institute for Health and Care Excellence, recommending additional imaging only when ultrasound was abnormal or in the few cases where recurrent febrile UTIs occurred [
7,
140‐
142]. Otherwise, they promoted a “watchful waiting” approach, with less emphasis on VUR given the lack of evidence that intervention is of any clinical benefit, except possibly for high grade IV–V VUR, which accounts for <5% of cases and is likely to be detected in the event of a second febrile UTI.
The European Association of Urology - European Society for Paediatric Urology 2015 was the only guideline formulated by surgeons that addresses investigation and management of a first febrile UTI in children. It advocated VCUG to detect VUR [
143] during the study period of this paper. The guideline has been recently updated, recommending VCUG following a first febrile UTI where an ultrasound was abnormal or the infection was due to an atypical organism [
147]. The authors of the guideline did not reference any RCT and lament the low quality of evidence cited, acknowledging most of the recommendations are based on “panel and expert opinion” [
148]. The relative lack of prospective well-designed studies involving elective surgical procedures (such as correction of VUR) is highlighted by data from major publicly-funded research bodies such as the UK’s National Institute for Health Research and Medical Research Council. Their combined spend on surgical research has been reported as <2% of the total research budget of £1.53 billion, even though 30% of National Health Service patients receive surgical care [
149]. Similar funding levels are reported in other countries [
137].
There appear to be two distinct directions in the literature on the investigation and management of febrile UTIs in children, one published predominantly by physicians in medical journals, and the other predominantly by surgeons in surgical journals. In undertaking this comparative study, we came to realize that, as physicians, almost all our reading has been in the medical literature, with the likelihood that surgeons may restrict their reading to the surgical literature. If we are to achieve consensus on the optimal management of conditions that cross boundaries between the physician and surgeon, as in the case of childhood febrile UTI, then improved collaboration in research as well as publications highlighting differences in points of view in both literatures is essential. Pediatric radiologists participate in multidisciplinary meetings and work closely with both pediatric nephrologists and surgeons. They may be in a good position to drive both research and consensus in the future.
How should the pediatric radiologist respond when asked to perform a VCUG in an otherwise normal child with a first febrile UTI? Firstly, the obvious disadvantages of the VCUG must be considered. Although a diagnostic study can be achieved with a relatively low radiation dose by using careful technique and modern equipment [
150], in practice the range of doses is extremely wide [
151]. It is worth noting that the European diagnostic reference level for dose-area product of 70 µGy·m
2 for a child aged between one month and four years [
150] corresponds to an effective dose of about 700 µSv, although this is at the upper end of a very wide range [
151]. The risk of induced cancer from this exposure depends on a controversial conversion factor, but for the purposes of informed consent could reasonably be estimated at one in 5,000. Most VCUG procedures are uneventful, but severe complications have been reported, including fatal sepsis [
152]. Finally, the psychological trauma of the procedure is difficult to quantify, but is probably significant, both for the patient and their carers [
153,
154].
The risk of a child without other congenital abnormalities of the kidney and urinary tract developing chronic kidney disease as a result of repeated febrile UTIs associated with VUR is very low [
3,
39,
155]. The shorter-term benefit of the possible prevention of further febrile UTIs by continuous antibiotic prophylaxis or a surgical intervention must be small, given that the probability of recurrence after a first febrile UTI is also known to be low [
39]. One small non-randomized study showed no advantage in terms of quality of life in those children who underwent surgery over those managed non-surgically [
156]. Studies with no control group are unlikely to provide useful data because the natural history of VUR is improvement through childhood. In the absence of a RCT of surgical versus non-surgical management of unselected patients found to have VUR after a first febrile UTI, there is no evidence that performing VCUG is of benefit in this context. Given that there are well-established risks of VCUG, it must be regarded as unwarranted. McAlister [
152], writing nearly 50 years ago, gave sound and succinct advice: “Cystography is not a benign procedure. It can result in death and a host of complications. It should be undertaken only when its findings have a reasonable chance of altering patient management.”
Potential limitations of the approach used here include exclusion of papers published in languages other than English, and coverage of a limited, although recent, time period.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.